APA (7th ed.) Citation

X, L., X, Z., X, Q., X, M., & K, X. (2021). Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Dove Medical Press.

Chicago Style (17th ed.) Citation

X, Liu, Zhu X, Qi X, Meng X, and Xu K. Co-Administration of IRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Dove Medical Press, 2021.

MLA (8th ed.) Citation

X, Liu, et al. Co-Administration of IRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy. Dove Medical Press, 2021.